Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-089249
Filing Date
2024-08-01
Accepted
2024-08-01 16:05:29
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20240630.htm   iXBRL 10-Q 2405927
2 EX-3.1 mrus-ex3_1.htm EX-3.1 350098
3 EX-31.1 mrus-ex31_1.htm EX-31.1 15908
4 EX-31.2 mrus-ex31_2.htm EX-31.2 15584
5 EX-32.1 mrus-ex32_1.htm EX-32.1 13225
  Complete submission text file 0000950170-24-089249.txt   9056375

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mrus-20240630.xsd EX-101.SCH 912934
58 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20240630_htm.xml XML 1743744
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 241166546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)